Trials / Conditions / Genotype 1
Genotype 1
6 registered clinical trials studyying Genotype 1.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasv NCT02669940 | AbbVie | — |
| Completed | Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy NCT01405027 | Chronic Liver Disease Foundation | Phase 4 |
| Completed | A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 NCT01194037 | HanAll BioPharma Co., Ltd. | Phase 1 / Phase 2 |
| Completed | A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic H NCT01121731 | Digna Biotech S.L. | Phase 1 / Phase 2 |
| Terminated | Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relaps NCT00882193 | University of Nebraska | EARLY_Phase 1 |
| Completed | Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336) NCT00863109 | Merck Sharp & Dohme LLC | — |